Patient Characteristics and Cardiac FDG-PET/CT Outcomes in Sarcoidosis

79 patients with cardiac sarcoidosis were analyzed for prognostic outcomes based on follow-up FDG-PET/CT imaging. The data includes patient characteristics, cardiac metabolic activity measurements, and major adverse cardiac event tracking from June 2013 to October 2023. Author Hideki Kawai published this dataset under a CC-BY-4.0 license.

Use Cases

• Predicting major adverse cardiac events based on cardiac FDG uptake status.
• Analyzing the relationship between left ventricular ejection fraction and long-term prognosis.
• Studying the temporal dynamics of cardiac metabolic activity in patients undergoing repeat PET imaging.
• Evaluating the prognostic significance of immunosuppressive therapy for cardiac sarcoidosis.

Strengths

• Data covers a 10-year period from June 2013 to October 2023.
• Includes quantitative measurements of cardiac metabolic activity for analysis.
• Dataset is small (9.5 KB), facilitating quick download and initial inspection.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is from a single retrospective study of 79 patients, limiting generalizability.

Provenance

Source

figshare

Collection Method

Retrospective analysis of patient records.

Time Range

June 2013–October 2023

Freshness

Last updated 2026-05-14 17:43:02; freshness should be verified.